Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Southpoint sells $7.5M worth stock of Fennec Pharmaceuticals [Seeking Alpha]

Fennec Pharmaceuticals Inc. (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
Company Research Source: Seeking Alpha
Southpoint Capital Advisors now holds ~2.7M common shares of Fennec Pharmaceuticals ( FENC ), representing about 8% of the company's outstanding shares. The shares were disposed of for investment purposes. More on Fennec Pharmaceuticals Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 Fennec Pharmaceuticals announces proposed offering of common shares Seeking Alpha's Quant Rating on Fennec Pharmaceuticals Historical earnings data for Fennec Pharmaceuticals Financial information for Fennec Pharmaceuticals Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
FENC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FENC alerts
Opt-in for
FENC alerts

from News Quantified
Opt-in for
FENC alerts

from News Quantified